How Boston Became 'The Best Place In The World' To Launch A Biotech Company
Baker-Polito Administration Proposes Life Sciences Initiative
LabCentral to add 42,000 square feet of new lab space in Kendall Square
Flagship-backed Rubius raises $120M to take off-the-shelf red blood cell cancer therapeutics into the clinic
Dragonfly Therapeutics Appoints World Leader in NK Therapeutics as Chief Scientific Officer
LogicBio Therapeutics Announces $50 Million in Financing to Develop Novel Gene Medicines for Pediatric Patients
LabCentral Gallery 1832 and Lobby Features Work Focusing on Cellular Structures by Stained Glass Artist and Biologist Joel Kowit, Ph.D.
Unum Therapeutics Announces Active Investigational New Drug (IND) Application for ACTR087 in Combination with SEA-BCMA in Patients with Relapsed/Refractory Multiple Myeloma
Stealthy Flagship cancer drug startup nabs $21M, new Kendall Square digs
Science Exchange Signs on as LabCentral Sponsor to Support Life Science and Biotech Startups with Outsourced R&D Services
